COVID-19: Oman begins administering 2nd dose of Pfizer vaccine from today

Vaccination programme is expected to move ahead seamlessly

Muscat: Oman’s Ministry of Health has started the second dose of the Pfizer BioNtech vaccine from today. The second jab of the inoculation that was delayed slightly has begun for the target group comprising of those in the medical field as well as those with specific health impairments among the general public group.

Accordingly, and as per directives from the Ministry of Health, the target group among the general community was identified as those over 65 years of age and with diabetes as well as those with chronic lung disease or suffering from kidney failure.

Among the health care workers, the target group comprises of those working in the ICU, staff working in COVID-19 wards, and those medical staff who have diabetes, chronic lung disease, those requiring dialysis as well as those whose BMI is more than or equal to 40.

Phase one

The first dose phase of the Pfizer vaccination was successfully concluded across the Sultanate and with the second shot process now having started the vaccination programme is expected to move ahead seamlessly.

The vaccine is administered at around 40 centres across Oman. Within the Muscat governorate the centres that are open for this are Al Seeb Specialised Polyclinic, Bausher Specialised Polyclinic and Quriyat Polyclinic.

Earlier this month, Oman kicked off the vaccination campaign for a new target group with AstraZeneca – Oxford vaccine. The new target group comprised of all those above 65 years of age, irrespective of any diseases.